Morningstar

Morningstar, Inc.

Equity Bottom-Up

We are dropping coverage of Qiagen. We provide broad coverage of more than 1,500 companies globally and periodically adjust our coverage according to investor interest and staffing configuration. We expect to reinitiate coverage of Qiagen later in the year.

<p>We are placing Qiagen under review as we transfer coverage to a new analyst. We expect to publish a new fair value estimate in the second quarter.</p>

Netherlands

QIAGEN N.V. is a global provider of Sample to Insight solutions to transform biological materials into valuable molecular insights. The Company provides its workflows to customers in Molecular Diagnostics (human healthcare), Applied Testing (forensics, veterinary testing and food safety), Pharma (pharmaceutical and biotechnology companies) and Academia (life sciences research).

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00